EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Advances in HIV Gene Therapy

Rose Kitawi, Scott Ledger, Anthony D Kelleher, Chantelle L Ahlenstiel iD

International Journal of Molecular Sciences · 28.02.2024 · 25 (5) · 2771

DOI: 10.3390/ijms25052771 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 28.02.2024. Verfasst von Rose Kitawi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Kirby Institute, University of New South Wales, Kensington, NSW 2052, Australia. Hauptthemen laut MEDLINE: HIV, HIV Infections. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 224 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council, Australian National Health and Medical Research Council Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Early gene therapy studies held great promise for the cure of heritable diseases, but the occurrence of various genotoxic events led to a pause in clinical trials and a more guarded approach to progress. Recent advances in genetic engineering technologies have reignited interest, leading to the approval of the first gene therapy product targeting genetic mutations in 2017. Gene therapy (GT) can be delivered either in vivo or ex vivo. An ex vivo approach to gene therapy is advantageous, as it allows for the characterization of the gene-modified cells and the selection of desired properties before patient administration. Autologous cells can also be used during this process which eliminates the possibility of immune rejection. This review highlights the various stages of ex vivo gene therapy, current research developments that have increased the efficiency and safety of this process, and a comprehensive summary of Human Immunodeficiency Virus (HIV) gene therapy studies, the majority of which have employed the ex vivo approach.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIVHIV InfectionsHumansGenetic VectorsGenetic TherapyGenetic EngineeringRNA

Stichwörter der Autor:innen

HIVex vivogene therapystem cellsvector

Substanzen

RNA

Autor:innen und Institutionen

  • Kirby Institute, University of New South Wales, Kensington, NSW 2052, Australia.
  • St. Vincent's Hospital, Darlinghurst, NSW 2010, Australia.
  • UNSW RNA Institute, University of New South Wales, Kensington, NSW 2052, Australia.

ORCID-Profile: Chantelle L Ahlenstiel

Förderung

  • National Health and Medical Research Council
  • Australian National Health and Medical Research Council Program

Zitieren

APA

Kitawi, R., Ledger, S., Kelleher, A. D., & Ahlenstiel, C. L. (2024). Advances in HIV Gene Therapy. International Journal of Molecular Sciences, 25(5), 2771. https://doi.org/10.3390/ijms25052771

Vancouver

Kitawi R, Ledger S, Kelleher AD, Ahlenstiel CL. Advances in HIV Gene Therapy. International Journal of Molecular Sciences. 2024;25(5):2771. doi:10.3390/ijms25052771

BibTeX
@article{Kitawi2024,
  author = {Kitawi, Rose and Ledger, Scott and Kelleher, Anthony D and Ahlenstiel, Chantelle L},
  title = {Advances in HIV Gene Therapy},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {5},
  pages = {2771},
  doi = {10.3390/ijms25052771}
}
Kostenlos starten →